• Morin: Next-Gen Modulator of Podocyte Energy and Renal Repai

  2026-05-07

  This thought-leadership article, authored in the voice of a scientific marketing head, explores Morin’s unique role as a mitochondrial energy metabolism modulator and anti-inflammatory flavonoid for diabetes research. Integrating mechanistic breakthroughs, experimental validation, and translational strategy, it provides actionable guidance for researchers targeting podocyte injury and energy dysregulation. The piece draws on cutting-edge primary literature, positions APExBIO Morin’s product advantages, and distinguishes itself with forward-looking commentary.

• Small Molecule Antagonists Targeting Shh/Heparin Binding: Fu

  2026-05-06

  Lamson et al. (2024) identified novel small molecule antagonists that inhibit Sonic hedgehog (Shh) binding to heparin, dissecting pathway specificity and demonstrating their functional impact in Hedgehog pathway assays. This evidence provides new tools for probing Hedgehog signaling mechanisms and highlights Shh/heparin interaction as a tractable target for basic and translational research.

• Morin Inhibits AMPD2 to Protect Podocyte Mitochondria in Fru

  2026-05-06

  This study reveals that Morin, a natural flavonoid, protects glomerular podocytes from fructose-induced mitochondrial dysfunction by directly inhibiting adenosine 5′-monophosphate deaminase (AMPD) activity—specifically AMPD2. The findings clarify a novel mechanism underlying Morin’s renoprotective effects and highlight AMPD2 as a therapeutic target in metabolic kidney injury.

• CP-673451 in Precision Oncology: Unlocking PDGFR-Targeted Th

  2026-05-05

  Explore how CP-673451, a selective PDGFRα/β inhibitor, advances cancer research with unique insights into ATRX-deficient glioma sensitivity, assay optimization, and translational implications. This article offers a deeper, protocol-driven perspective distinct from existing reviews.

• SGI-1027: Precision DNA Methyltransferase Inhibitor for Canc

  2026-05-05

  SGI-1027 is a potent DNA methyltransferase inhibitor that directly targets DNMT1 to induce demethylation and reactivate tumor suppressor genes. Recent evidence demonstrates its efficacy in inhibiting gastric cancer cell growth and metastasis by modulating RB1 gene expression. This article compiles peer-reviewed data, protocol benchmarks, and workflow integration guidance for SGI-1027 in epigenetic research.

• Deep Learning of USC Mitochondria Reveals AD Biomarker Poten

  2026-05-04

  This study pioneers a deep learning framework to non-invasively assess mitochondrial morphology in urine-derived stem cells from Alzheimer's disease patients. The approach demonstrates robust discrimination of disease-associated mitochondrial states, offering a promising new biomarker strategy for early detection and real-time monitoring.

• miR-196a Drives Esophageal Adenocarcinoma via MYC/TERT/NFκB

  2026-05-04

  This study reveals that microRNA-196a promotes the aggressiveness of esophageal adenocarcinoma (EAC) by activating the MYC/TERT/NFκB signaling axis. Mechanistic dissection demonstrates that miR-196a enhances epithelial-mesenchymal transition and cell motility, providing a clear molecular pathway that may be targeted for future cancer interventions.

• Applied Workflows with EZ Cap™ Human PTEN mRNA (ψUTP) in Can

  2026-05-03

  EZ Cap™ Human PTEN mRNA (ψUTP) empowers researchers to restore PTEN function and robustly inhibit PI3K/Akt signaling in resistant cancer models. This article details practical workflows, experimental parameters, and troubleshooting strategies that leverage its uniquely stable, immune-evasive design.

• Isoprinosine: Applied Immunotherapy in Acute Viral Infection

  2026-05-02

  Isoprinosine (inosine pranobex) stands out as a dual-action immunomodulatory agent for acute respiratory viral infections, offering a reproducible edge in both viral inhibition and immune enhancement. This article bridges bench protocols, troubleshooting, and recent mechanistic advances—empowering researchers to optimize immunotherapy and antiviral workflows with confidence.

• Plant Exosome-like Nanovesicles Mitigate Testicular Injury v

  2026-05-02

  This study introduces Cistanche deserticola-derived exosome-like nanovesicles (CDELNs) as a novel intervention to alleviate cyclophosphamide-induced testicular injury by targeting cell cycle arrest in Sertoli cells. The findings highlight the therapeutic potential of plant nanovesicles in male reproductive health and provide a mechanistic framework for further translational applications.

• Azithromycin and Roxithromycin: Repurposed Senolytics in Fib

  2026-05-01

  This study identifies azithromycin and roxithromycin, two macrolide antibiotics, as selective senolytic agents capable of efficiently eliminating senescent human fibroblasts. The findings reveal distinct metabolic and autophagic mechanisms underlying their activity and provide actionable insights for cellular senescence assay development and drug screening.

• Applied Workflows with Tetrandrine Alkaloid in Ion Channel S

  2026-04-30

  Tetrandrine alkaloid distinguishes itself as an indispensable tool in ion channel modulation and neuroscience research, offering robust DMSO solubility and validated performance. This guide details hands-on workflows, optimization strategies, and troubleshooting insights to unlock the full potential of Tetrandrine in advanced cell signaling and cancer biology experiments.

• AQP9 Downregulation Drives Proliferation in KRASG12V Colorec

  2026-04-30

  This study reveals that KRASG12V mutations in colorectal cancer are associated with reduced AQP9 expression, leading to increased tumor proliferation and decreased apoptosis. The findings clarify novel molecular links and highlight AQP9 as a potential therapeutic target, with implications for diagnostic and mechanistic research.

• EZ Cap Cy5 Firefly Luciferase mRNA: Dual-Mode Tracking Innov

  2026-04-29

  Explore the scientific advantages of EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) for advanced mRNA delivery and real-time intracellular imaging. This article unveils unique dual-reporter strategies and actionable assay insights for translational research.

• GPR107 Deficiency Drives Collagen IV Accumulation in Diabeti

  2026-04-29

  Xu et al. uncover how G protein-coupled receptor 107 (GPR107) loss exacerbates diabetic nephropathy by disrupting the endocytic regulation of collagen type IV in podocytes. Their mechanistic study links GPR107 to AT1R/Ca2+ signaling and highlights new therapeutic targets for renal fibrosis.

16946 records 1/1130 page Next 12345 下5页 Last page